To determine the cytotoxic potential of CD155 CAR-T cells against CD155+ solid tumors, we cocultured the aforementioned tumor cell lines with either mock T cells or CD155 CAR-T cells at different E/T ratios and conducted cytometry-based killing assays. This evidence concerns the gene PVR and neoplasm.